Assessing DNA for areas of the genome linked to cancer risk could pick out some people with a three-fold increased risk of blood cancer, a new study suggests.

Researchers have revealed 40 genes involved in the development of myeloma, increasing our understanding of the complex genetics behind the incurable blood cancer.

Potential new drugs that block a safeguard used by cancer cells to stay alive in stressful conditions have shown promise against myeloma, a cancer of white blood cells made in the bone marrow, a new study reports.